Manish A. Vira, MD, Joph Steckel, MD, FACS The goal of presurgical testing is to identify undiagnosed comorbidity or significant exacerbation of existing comorbid illnesses that may affect the operative outcome (Townsend et al, 2008). Although the preoperative evaluation should be individualized on the basis of age, history, and physical examination, each hospital or surgery center generally has specific guidelines for the necessary presurgical tests. Interestingly, routine testing has never been shown to be cost effective. In fact, it is less predictive of perioperative morbidity than the American Society of Anesthesiologists (ASA) status or the American Heart Association (AHA)/American College of Cardiology (ACC) guidelines for surgical risk. Generally, presurgical testing includes complete blood count (CBC), basic metabolic panel (BMP), prothrombin time/partial prothrombin time/international normalized ratio (PT/PTT/INR; controversial), electrocardiogram (ECG), and chest radiograph. The routine use of a PT/PTT in a patient not using warfarin or in a patient who gives no prior history of increased bleeding with other surgical procedures is controversial. Often overlooked but extremely important is the requirement for a urine pregnancy test on the morning of surgery in any woman of childbearing age unless the ovaries or uterus have been previously surgically removed (Halaszynski et al, 2004). The value of a preoperative ECG in identification of underlying acute cardiac disease and predicting perioperative cardiac morbidity is also controversial. Some studies show that ECG abnormalities have no significant predictive value (Goldman et al, 1978), whereas others have shown that an abnormal ECG was the best diagnostic predictor of an adverse cardiac event (Carliner et al, 1985). Nonetheless, current recommendations generally suggest that a preoperative ECG be done in patients older than 40 years of age or those with a history of any cardiac disease. Similarly, the routine preoperative use of a chest radiograph, in the absence of preexisting cardiopulmonary disease, is not indicated. Overall, even an ASA Task Force on preanesthesia evaluation could not make firm recommendations other than “preoperative tests may be ordered, required, or performed on a selective basis for purposes of guiding or optimizing perioperative management” (Practice advisory, 2002). The goal of the classification system is to assess the overall physical status of the patient before surgery (not to assess surgical risk), and although quite subjective, it remains as a significant independent predictor of mortality (Davenport et al, 2006). Other tools to assess the preoperative risks were developed by multivariate statistical analysis of patient-related factors correlated with surgical outcomes. One such scoring system, Goldman’s criteria (Table 6–1), assigns points to easily reproducible characteristics. The points are then added to compute the perioperative risk of cardiac-related complication. Another system, the Cardiac Risk Index, simplified this concept employing only six predictors to estimate cardiac complication risk in noncardiac surgical patients (Table 6–2) (Akhtar and Silverman, 2004). Adapted from Akhtar S, Silverman DG. Assessment and management of patients with ischemic heart disease. Crit Care Med 2004;32:S126–36. Adapted from Akhtar S, Silverman DG. Assessment and management of patients with ischemic heart disease. Crit Care Med 2004;32:S126–36. The preoperative cardiac evaluation, which consists of an initial history and physical examination and ECG, attempts to identify potential serious cardiac disorders such as coronary artery disease, heart failure, symptomatic arrhythmias, the presence of a pacemaker or implantable defibrillator, or a history of orthostatic hypotension (Eagle et al, 1996). Furthermore, it is essential to define the severity and stability of existing cardiac disease before surgery. Cardiac-specific risk is also altered by the patient’s functional capacity, age, and other comorbid conditions such as diabetes, peripheral vascular disease, renal dysfunction, and chronic obstructive pulmonary disease. The American College of Cardiology and American Heart Association recently collaborated to develop guidelines regarding perioperative cardiac evaluation before surgery (Fleisher et al, 2007a). The guidelines generally use three categories of clinical risk predictors: clinical markers, functional capacity, and type of surgical procedure (Eagle et al, 2002). The major clinical predictors of increased perioperative cardiovascular risk are a documented acute myocardial infarction less than 7 days previously, a recent myocardial infarction (defined as >7 days but <1 month before surgery), unstable angina, evidence of any ischemic burden by clinical symptoms or noninvasive testing, decompensated heart failure, significant arrhythmias, and severe valvular disease. Intermediate predictors include mild angina, previous myocardial infarction by history or pathologic Q waves, compensated heart failure, diabetes, or renal insufficiency (creatinine >2 mg/dL). Minor predictors of risk are advanced age, abnormal electrocardiogram, rhythms other than sinus (i.e., atrial fibrillation), history of stroke, or uncontrolled systemic hypertension. The historical dictum of the timing of elective surgery after a myocardial infarction into a 3-month and 6-month interval is now currently avoided (Tarhan et al, 1972). The ACC cardiovascular database committee stratifies risk on the basis of the severity of the myocardial infarction and the likelihood of reinfarction based on a recent exercise stress test. However, in the absence of adequate clinical trials on which to base firm recommendations, it is reasonable to wait 4 to 6 weeks after myocardial infarction to perform elective surgery. Functional capacity, or one’s ability to meet aerobic demands for a specific activity, is quantified as metabolic equivalents or METs. For example, a 4-MET demand is comparable with a patient’s ability to climb two flights of stairs. This simple measurement continues to be an easy and inexpensive method to determine a patient’s cardiopulmonary functional capacity (Biccard, 2005). The Duke Activity Status Index (Table 6–3) allows the physician to easily determine a patient’s functional capacity (Hlatky et al, 1989). Generally, a capacity of 4 METs indicates no further need for invasive cardiac evaluation. Duke activity status index (DASI) = SUM (values for all 12 questions). Estimated Peak Oxygen Uptake (VO2peak) in mL/min = (0.43 × [DASI]) + 9.6. VO2peak mL/kg/min × 0.286 (mL/kg/min)−1 = METS. * The most widely recognized measure of cardiorespiratory fitness is maximal oxygen consumption (VO2peak) measured in mL/kg/min. The Index score correlates directly with VO2peak and therefore is an indirect measure of maximal METS. Adapted from Hlatky MA, Boineau RE, Higginbotham MB, et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 1989;64:651–4. Two important factors determine the surgery-specific cardiac risk: the type of surgery and the degree of hemodynamic stress. Surgery-specific risk is stratified into high-, intermediate-, and low-risk procedures. High-risk procedures include both major emergent surgery, particularly in the elderly, and surgery associated with increased operative time resulting in large fluid shifts or blood loss. Intermediate risk procedures include intraperitoneal surgery, laparoscopic procedures, and robotic-assisted laparoscopic surgeries. Low-risk procedures include endoscopic procedures or superficial surgeries (i.e., not involving entrance into a body cavity) (Eagle et al, 2002). Preoperative pulmonary evaluation is important in all urologic procedures but critical in those surgeries involving the thoracic or abdominal cavities. These later procedures, which include intra-abdominal, laparoscopic, or robotic surgeries, can decrease pulmonary function and predispose to pulmonary complications. Accordingly, it is wise to consider pulmonary functional assessment in patients who have significant underlying medical disease, significant smoking history, or overt pulmonary symptoms. Pulmonary function tests that include a forced expiratory volume in 1 second (FEV1), forced vital capacity, and the diffusing capacity of carbon monoxide are quite easily obtainable and provide a preoperative baseline. Patients with an FEV1 of less than 0.8 L/sec or 30% of predicted are at high risk for complications (Arozullah et al, 2003). Specific pulmonary risk factors include chronic obstructive pulmonary disease, smoking, preoperative sputum production, pneumonia, dyspnea, and obstructive sleep apnea. It has been shown that smokers have a fourfold increased risk for postoperative pulmonary morbidity and as high as a 10-fold higher mortality rate (Fowkes et al, 1982). In general, it is interesting to note that patients with restrictive pulmonary disease fare better than those with obstructive pulmonary disease because the former group maintains an adequate maximal expiratory flow rate, which allows for a more effective cough with less sputum production (Pearce and Jones, 1984). In addition to the specific pulmonary risk factors, general factors contribute to increased pulmonary complications such as increased age, lower serum albumin levels, obesity, impaired sensorium, previous stroke, immobility, acute renal failure, and chronic steroid use. Specific preoperative interventions can decrease pulmonary complications. Smoking must be discontinued at least 8 weeks before surgery to achieve a risk reduction. Patients who discontinue smoking less than 8 weeks before surgery may actually have a higher risk of complication because the acute absence of the noxious effect of cigarette smoke decreases postoperative coughing and pulmonary toilet. However, patients who have stopped smoking at least 8 weeks preoperatively will significantly lower their complication rate, and patients who have ceased smoking for more than 6 months have a pulmonary morbidity comparable with nonsmokers (Warner et al, 1989). The use of preoperative bronchodilators in COPD patients can dramatically reduce postoperative pulmonary complications. Aggressive treatment of preexisting pulmonary infections with antibiotics, as well as the pretreatment of asthmatic patients with steroids, is essential in optimizing pulmonary performance. Likewise, the use of epidural and regional anesthetics, vigorous pulmonary toilet, rehabilitation, and continued bronchodilation therapy are all beneficial (Arozullah et al, 2003). The Child classification assesses perioperative morbidity and mortality in patients with cirrhosis and is based on the patient’s serum markers (bilirubin, albumin, prothrombin time) and severity of clinical manifestations (i.e., encephalopathy and ascites). Mortality risk for patients undergoing surgery stratified by Child class is as follows: Child Class A—10%, Child Class B—30%, and Child Class C—76% to 82%. The Child classification also correlates with the frequency of complications such as liver failure, encephalopathy, bleeding, infection, renal failure, hypoxia, and intractable ascites. Independent risk factors other than the Child class that can increase the mortality rate in patients with liver disease include emergency surgery and chronic obstructive pulmonary disease (O’Leary et al, 2009; Pearce and Jones, 1984). The MELD score is perhaps a more accurate assessment of perioperative mortality in patients with hepatic dysfunction. The score is derived from a linear regression model based on serum bilirubin, creatinine levels, and the international normalized ratio (INR). It is more accurate than the Child classification in that it is objective, gives weights to each variable, and does not rely on arbitrary cut-off values (Teh et al, 2007). Clinicians can use a website (http://mayoclinic.org/meld/mayomodel9.html) to calculate the 7-day, 30-day, 90-day, 1-year, and 5-year surgical mortality risk on the basis of the patient’s age, ASA class, INR, serum bilirubin, and creatinine levels. Taken together, the Child classification and the MELD score complement each other and provide an accurate assessment of the risk of surgery in cirrhotic patients (O’Leary and Friedman, 2007; O’Leary et al, 2009). Just as adequate preoperative evaluation is important, optimization of comorbid illness is critical in reducing perioperative morbidity and mortality. With regards to cardiac disease, many studies have evaluated the prophylactic use of nitrates, calcium-channel blockers, and β-blockers for patients who are at risk for perioperative myocardial ischemia. Only β-blockade has shown to improve outcomes (Pearse et al, 2004). In a landmark study, Mangano and colleagues reported in the New England Journal of Medicine that there was an improvement in outcomes with the prophylactic use of atenolol in patients undergoing vascular surgery (Mangano et al, 1996). Similarly, a retrospective, cooperative group study of more than half a million patients showed that perioperative beta blockade is associated with a reduced risk of death among high-risk patients undergoing major noncardiac surgery (Lindenauer et al, 2005). In addition to β-blockade, the concept of goal-directed therapy, employing the judicious use of fluids, inotropes, and oxygen therapy to achieve therapeutic goals, may further reduce perioperative risk (Pearse et al, 2004). This concept was validated by Shoemaker, who reported an impressive reduction in mortality from 28% to 4% (P < .02) when goal-directed therapy was used (Shoemaker et al, 1988). As with cardiac comorbidity, the preoperative management of the diabetic patients is quite important. Perioperative hyperglycemia can lead to impaired wound healing and a higher incidence of infection (Golden et al, 1999). Hypoglycemia in an anesthetized or sedated diabetic patient may be unrecognized and carries its own significant risks. Noninsulin diabetics may need to discontinue long-acting hypoglycemics because of this risk of intraoperative hypoglycemia. Shorter-acting agents or sliding scale insulin regimens are generally preferable. It is recommended that blood glucose levels be controlled between 80 and 250 mg/dL. Frequent fingerstick glucose checks and the use of a sliding scale short-acting insulin regimen are used in the postoperative period. Once the patient is eating, the usual insulin regimen can be resumed. Patients who monitor their diabetes with the use of insulin pumps should continue their basal insulin infusions on the day of surgery. The pump is then used to correct the glucose level as it is measured. It is important to know the sensitivity factor that corrects the glucose so that the patient’s sugars can be managed in the operating room (Townsend et al, 2008). Patients with either hyperthyroidism or hypothyroidism should be evaluated by an endocrinologist and surgery should be deferred until a euthyroid state is achieved. The greatest risk in the hypothyroid patient is thyrotoxicosis or thyroid storm, which can present with fevers, tachycardia, confusion, and cardiovascular collapse. Atrial fibrillation may also be present in 20% of hyperthyroid patients (Klein and Ojamaa, 2001). With regards to hyperthyroidism, careful attention should be given to the airway because the trachea can be compressed or deviated by a large goiter. Generally, antithyroid medications such as propylthiouracil or methimazole, as well as β-blockers, are continued on the day of surgery. In the event of thyroid storm, iodine and steroids may be necessary (Schiff and Welsh, 2003). Hypothyroidism is generally associated with an increased sensitivity to medications such as anesthetic agents and narcotics. Severe hypothyroidism can be associated with myocardial dysfunction, coagulopathy, electrolyte imbalance, and a decreased gastrointestinal motility. Symptoms include lethargy, cold intolerance, hoarseness, constipation, dry skin, and apathy. The decrease in metabolic rate produces periorbital edema, thinning of the eyebrows, brittle hair, dry skin, hyperthermia, bradycardia, and a prolonged relaxation of the deep tendon reflexes (Murkin, 1982). Once the diagnosis is confirmed by a low thyroxine level and an elevated thyroid stimulating hormone level, thyroid replacement with levothyroxine can be initiated (Schiff and Welsh, 2003). The evaluation of the patient either taking corticosteroids or suspected of having an abnormal response of the hypothalamic-pituitary-adrenal axis (HPA) is also important. There is a wide variability in the HPA suppression in patients on exogenous steroids. Nonetheless, it seems clear that oral steroids equivalent to less than 5 mg of prednisone for any duration of time does not cause clinically significant suppression of the HPA axis. By contrast, any patient taking more than 20 mg of prednisone or its equivalent per day for more than 3 weeks or who is clinically Cushingoid has probable HPA axis suppression (LaRochelle et al, 1993). HPA suppression can even occur in patients using potent topical steroids at doses of 2 g per day, as well as in patients using inhaled corticosteroids at doses of 0.8 mg per day. Although the duration of a functional HPA axis suppression after glucocorticoids have been stopped is debatable, perioperative supplemental steroids are recommended for patients who had HPA axis suppressive doses within 1 year of surgery. A low-dose ACTH stimulation test can be used to assess the HPA axis and the need for stress steroids. For patients who take 5 mg of prednisone or the equivalent each day, no supplemental steroids are necessary and the usual daily glucocorticoid dose may be given in the perioperative period. For those in whom the HPA axis is presumed to be suppressed or is documented to be suppressed, then 50 to 100 mg of intravenous hydrocortisone is given before the induction of anesthesia and 25 to 50 mg of hydrocortisone is given every 8 hours thereafter for 24 to 48 hours until the usual steroid dose can be resumed. Minor procedures under local anesthesia do not require stress-dose steroids (Schiff and Welsh, 2003). In the next 20 years, the percentage of patients older than 85 years of age may reach 5% or 15 million people. This represents a rapidly growing segment of our aging population (Monson et al, 2003). Accordingly, octogenarians and nonagenarians are undergoing an increasing number of surgeries annually. Because of the elderly patients’ special physiologic, pharmacologic, and psychologic needs, a unique set of health care challenges are encountered. It is still unclear whether advanced age independently predicts surgical risk or whether it is coexisting medical conditions that adversely affect surgical outcomes. However, in a large study published by Turrentine, it was shown that increased age independently predicted morbidity and mortality (Turrentine et al, 2006). This confirmed the study by Vemuri, who also found increased age as an independent risk factor for morbidity and mortality in patients undergoing aneurysm surgery (Vemuri et al, 2004). The studies suggest that perhaps the elderly patient cannot meet the increased functional demand required during perioperative and postoperative period. Hypertension and dyspnea were the most frequently seen comorbid risk factors in patients older than 80 years, and preoperative transfusion history, emergency operation, and weight loss best predicted postoperative morbidity. Each 30-minute increment of operative time increased the odds of mortality by 17% in octogenarians (Turrentine et al, 2006). A unique and important factor in the perioperative care of the elderly is in the identification and prevention of delirium. Often overlooked as “sundowning,” delirium can be the first clinical sign of metabolic and infectious complications (Townsend et al, 2008). With the rising incidence of obesity, as well as the vast experience gathered from bariatric surgery, the care of the morbidly obese patient has been extensively studied. One must carefully weigh the risk of any surgical procedure with the natural history of the disease when deciding the optimal time of the surgery in the morbidly obese. It is estimated that patients with a body mass index (BMI) of greater than or equal to 45 kg/m2 may lose anywhere from 8 to 13 years of life (Fontaine et al, 2003). The careful selection of the morbidly obese patient for elective surgery is of paramount importance. Cardiac symptoms such as exertional dyspnea and lower extremity edema are nonspecific in the morbidly obese patients, and many of these patients have poor functional capacity. The physical examination often underestimates cardiac dysfunction in the severely obese patient. Severely obese patients with greater than three coronary heart disease risk factors may require noninvasive cardiac evaluation (Poirier et al, 2009). Obesity is associated with a vast array of comorbidities. Morbidly obese patients often have atherosclerotic cardiovascular disease, heart failure, systemic hypertension, pulmonary hypertension related to sleep apnea and obesity, hypoventilation, cardiac arrhythmias, deep vein thrombosis, history of pulmonary embolism, and poor exercise capacity. There are also numerous pulmonary abnormalities that result in a ventilation perfusion mismatch and alveolar hypoventilation. Obesity is a risk factor for postoperative wound infections, and, when appropriate, laparoscopic surgery should be considered. Urologic surgery in the pregnant woman is generally related to the management of renal colic and urinary tract stones. In the asymptomatic woman, the stones can be discovered during the sonographic evaluation of the fetus or during the evaluation of the pregnant woman who is experiencing renal colic. The fetus is at the highest risk from radiation exposure from the preimplantation period to approximately 15 weeks’ gestation. Because the radiation dose that is associated with congenital malformations is 10 cGy, the evaluation of renal colic in a pregnant patient is performed usually with sonography (radiation dose with abdominal CT: 1 cGy, intravenous pyelogram: 0.3 cGy). The indications for operative intervention in the pregnant patient are discussed elsewhere in this book. Anesthetic risks during pregnancy concern both the mother and the fetus. During the first trimester, the fetus may be directly exposed to the teratogenic effects of certain anesthetic agents. Later in pregnancy, anesthesia places the mother at risk for preterm labor and the fetus at risk for hypoxemia secondary to changes in uterine blood flow and maternal acid base balance. These risks seem to be greatest during the first and third trimesters. For semielective procedures, an attempt should be made to delay surgery until after the first trimester. However, one must consider the continued exposure of the underlying condition in relation to the operative risks to both the mother and the fetus. The second trimester is the safest time to perform surgery because organ system differentiation has occurred and there is almost no risk for anesthetic-induced malformation or spontaneous abortion. When contemplating surgery on the pregnant female, consultation with the obstetrician, perinatologist, and anesthesiologist is essential. These specialists will help determine the optimum technique to monitor the status of the fetus in the pregnant mother. Fetal heart rate monitors and tocometer monitoring for uterine activity are used before and after the procedure. Postoperative pain is best managed with narcotic analgesics because they have not been shown to cause birth defects in humans when used in normal dosages. Nonsteroidal anti-inflammatory medication should be avoided because of the risk for premature closure of the ductus arteriosus. Chronic use of narcotics during pregnancy may cause fetal dependency, and it is recommended that the pregnant postsurgical patient be weaned off narcotic use as soon as possible (Mikami et al, 2008). Malnutrition compromises host defenses and increases the risk of perioperative morbidity and mortality. Adequate nutritional status is essential for proper wound healing, management of infections, return of gastrointestinal activity, and maintenance of vital organ function (McDougal, 1983). The preoperative evaluation of the patient’s nutritional status consists of the assessment of any recent weight loss and the measurement of the lymphocyte count and serum albumin. A 20-pound weight loss in the preceding 3 months before surgery is considered to be a reflection of severe malnutrition. The lymphocyte count and serum albumin level reflect visceral protein status with lower levels indicating malnutrition (Reinhardt et al, 1980). There are two methods for nutritional support. Total parenteral nutrition (TPN) is used for patients who are severely malnourished and who have a nonfunctioning gastrointestinal tract. Several studies have shown that 7 to 10 days of preoperative parenteral nutrition improves postoperative outcome in undernourished patients (Von Meyenfeldt et al, 1992). On the contrary, its use in well-nourished or mildly undernourished patients is either of no benefit or even with increased risk of sepsis (Perioperative total parenteral nutrition in surgical patients, 1991). On the other hand, enteral nutrition has a fewer complications than TPN and can provide a more balanced physiologic diet. Elemental nutrition is accomplished via a feeding tube, a gastrostomy, or feeding jejunostomy. Enteral nutrition maintains the gut-associated lymphoid tissue, enhances mucosal blood flow, and maintains the mucosal barrier. There are hundreds of enteral products on the market, and most have a caloric density of 1 to 2 kcal/mL. These formulas are also lactose free and provide the recommended daily allowances of vitamins and minerals in less than 2 L per day. The patients on enteral feeds must be monitored for improvement in nutritional status, gastrointestinal intolerance, and fluid and electrolyte imbalance. Preoperative enteral feedings can decrease postoperative complication rates by 10% to 15% when used for 5 to 20 days before surgery (Guidelines, 2002). The guidelines recommend postoperative parenteral nutrition in patients who are unable to meet their caloric requirements within 7 to 10 days. Just as in the perioperative state, enteral feedings are preferred over parenteral nutrition when feasible. Moreover, the routine use of postoperative TPN has not proven useful in well-nourished patients or in those with adequate oral intake within 1 week after surgery (Byers and Hameed, 2008). Complications can occur with either enteral nutrition or parenteral nutrition. Dislodgement of nasoenteral tubes and percutaneous enteral catheters can result in pulmonary and peritoneal complications. Adynamic ileus may also occur because of decreased splanchnic perfusion, sympathetic tone, or opiate use. With regards to TPN, establishing central access is associated with a significant risk of complications. These include pneumothorax/hemothorax secondary to poor line placement and chylothorax secondary to thoracic duct injury. Line sepsis is the most common complication of indwelling central catheters and necessitates catheter removal. Venous thrombosis with associated thrombophlebitis and extremity edema has been reported. Catheter thrombosis has also been reported and can be treated with thrombolytic agents (Guidelines, 2002). In 1999 the Centers for Disease Control (CDC) issued its third report on the prevention of surgical site infections (SSIs) highlighting the importance of standardization of prophylaxis treatment to prevent this universal surgical complication (Mangram et al, 1999). The report indicated that SSIs account for approximately 40% of nosocomial infections in surgical patients and potentially prolong hospital stay by 7 to 10 days. A study of national SSIs from the 2005 Healthcare Cost and Utilization Project National Inpatient Sample (HCUP NIS) calculated an increase in hospital stay of 9.7 days and in per-patient cost of $20,892 (de Lissovoy et al, 2009). This translated nationally into an additional 1 million inpatient hospital days and additional health care cost of $1.6 billion. Bowater and colleagues recently published a systematic review of meta-analyses (level 1 evidence) and concluded that there was substantial evidence that antibiotic prophylaxis was an effective prevention for SSI over a wide variety of surgical procedures (Bowater et al, 2009). Given both the ethical responsibility of the surgeon to decrease surgical morbidity and the recent policy shift by the Centers of Medicare and Medicaid Services to withhold reimbursement for hospital admissions secondary to specific SSI, it is mandatory for urologists to understand the principles behind and practice SSI prevention. Along with antibiotic prophylaxis, proper hand washing/scrubbing and sterile preparation of the operative field have always been central to the prevention of SSI. For procedures involving the gastrointestinal tract, mechanical and oral antibiotic bowel preparation had been standard practice until more recent literature calling into question its usefulness (discussed later). Preoperative hair removal has not been associated with a decrease in SSI, but if performed, use of mechanical clippers or depilatory creams as opposed to razors are associated with a decrease risk of SSI (Wolf et al, 2008). The risk of SSI and therefore the recommendation for antibiotic prophylaxis is composed of three risk factors: the patient’s susceptibility to and the ability to respond to localized and systemic infection, procedural risk of infection, and the potential morbidity of infection. Patient-related factors, listed in Table 6–4, increase risk by decreasing natural defenses, increasing the local bacterial concentration, and/or altering the spectrum of bacterial flora. Secondly, surgical procedure–specific factors can affect the route of entry, site of infection, and pathogen involved. This idea was first described in the landmark study from the National Research Council and later formalized by the CDC; specifically, surgical wounds are now classified by degree of contamination (i.e., the inoculum of potential pathogen) (Table 6–5; Hart et al, 1968). To predict the risk of SSI, several scoring systems have been developed incorporating patient-related factors with wound classification. Finally, the risk to the patient from SSI is an important consideration in determining the need for prophylaxis. For example, routine cystoscopy in the evaluation of microhematuria in an otherwise young, healthy patient may not warrant prophylaxis; however, the same procedure in an elderly, insulin-dependent diabetic (immunocompromised) does warrant prophylaxis given the high likelihood that a postprocedural urinary tract infection would result in a significant deterioration in the patient’s overall health. Understanding the three factors together then allows the urologist to make a rational decision as to the risk/benefit of antibiotic prophylaxis. Data from Cruse PJ. Surgical wound infection. In: Wonsiewicz MJ, editor. Infectious disease. Philadelphia: WB Saunders; 1992. p. 758–764; and Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999;20:250–78; quiz 279–80. Data from Garner JS. CDC guideline for prevention of surgical wound infections, 1985. Supersedes guideline for prevention of surgical wound infections published in 1982. (Originally published in 1995.) Revised. Infect Control 1986;7(3):193–200; and Simmons BP. Guideline for prevention of surgical wound infections. Infect Control 1982;2:185–96. Once the decision for antibiotic prophylaxis is made, the keys to successful prevention are proper timing and administration of the antibiotic and the proper choice of antibiotic for the particular procedure. Since the pivotal study by Classen and colleagues, particular emphasis has been placed on the timing of prophylaxis to be given within 2 hours of incision (Classen et al, 1992
Presurgical Testing
Surgical Risk Evaluation
American Society of Anesthesiologists Classification and Risk Stratification
PATIENT RISK FACTORS
POINTS
Third heart sound or jugular venous distention
11
Recent myocardial infarction
10
Nonsinus rhythm or premature atrial contraction on electrocardiogram
7
>5 premature ventricular contractions
7
Age >70 yr
5
Emergency operations
4
Poor general medical condition
3
Intrathoracic, intraperitoneal, or aortic surgery
3
Important valvular aortic stenosis
3
For noncardiac surgery, the risk of cardiac complications are:
PATIENT RISK FACTORS
POINTS
Ischemic heart disease
1
Congestive heart failure
1
Cerebral vascular disease
1
High-risk surgery
1
Preoperative insulin treatment for diabetes
1
Preoperative creatinine of ≥2 mg/dL
1
Each increment in point increases risk of perioperative cardiovascular morbidity
Cardiac Evaluation
Clinical Markers
Functional Capacity
ACTIVITY
YES
NO
Can you take care of yourself (eating, dressing, bathing, or using the toilet)?
2.75
0
Can you walk indoors such as around your house?
1.75
0
Can you walk a block or two on level ground?
2.75
0
Can you climb a flight of stairs or walk up a hill?
5.50
0
Can you run a short distance?
8.00
0
Can you do light work around the house like dusting or washing dishes?
2.70
0
Can you do moderate work around the house like vacuuming, sweeping floors, or carrying in groceries?
3.50
0
Can you do heavy work around the house like scrubbing floors or lifting and moving heavy furniture?
8.00
0
Can you do yardwork like raking leaves weeding or pushing a power mower?
4.50
0
Can you have sexual relations?
5.25
0
Can you participate in moderate recreational activities like golf, bowling, dancing, doubles tennis, or throwing a baseball or football?
6.00
0
Can you participate in strenuous sports like swimming, singles tennis, football, basketball, or skiing?
7.50
0
Surgery-Specific Cardiac Risk
Pulmonary
Hepatobiliary
Optimization of Comorbid Illness
Special Populations
Elderly
Morbid Obesity
Pregnancy
Nutritional Status
Preparation for Surgery
Antibiotic Prophylaxis
Clean
Clean contaminated
Contaminated
Dirty infected
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
Core Principles of Perioperative Care
• Uninfected wound with major break in sterile technique (gross spillage from gastrointestinal tract or nonpurulent inflammation)